\begin{thebibliography}{10}

\bibitem{open_intro}
W.~Cao, H-D. Chen, Y-W. Yu, N.~Li, W-Q. Chen, and J.~Ni.
\newblock Changing profiles of cancer burden worldwide and in china: a
  secondary analysis of the global cancer statistics 2020.
\newblock {\em Chinese Medical Journal}, 134(07):783--791, 2021.

\bibitem{Jemal}
F.~Bray, J.~Ferlay, I.~Soerjomataram, R.~L. Siegel, L.A. Torre, and A.~Jemal.
\newblock Global cancer statistics 2018: Globocan estimates of incidence and
  mortality worldwide for 36 cancers in 185 countries.
\newblock {\em CA Cancer J Cling}, 68(2):394--424, 2018.

\bibitem{bc_numbers}
M.~Mohammadian, A.~Safari, K.~A. Bakeshei, F.~A. Bakeshei, A.~Asti,
  A.~Mohammadian-Hafshejani, H.~Salehiniya, M.~Emaiyan, and H.~Khapour.
\newblock Recent patterns of bladder cancer incidence and mortality: A global
  overview.
\newblock {\em World cancer Research Journal}, 7:e1464, 2020.

\bibitem{noninvasive_bc}
M.~A. Knowles.
\newblock Molecular subtypes of bladder cancer: Jekyll and hyde or chalk and
  cheese?
\newblock {\em Carcinogenesis}, 27(3):361--373, 2006.

\bibitem{bc_chemotherapy}
C.~Vale.
\newblock Neoadjuvant chemotherapy in invasive bladder cancer: a systematic
  review and meta-analysis.
\newblock {\em The Lancet}, 361:1927--1934, 2003.

\bibitem{bcg_best}
G.~Urdaneta, E.~Solsona, and J.~Palou.
\newblock Intravesical chemotherapy and bcg for the treatment of bladder
  cancer: evidence and opinion.
\newblock {\em European Urology Supplements}, 7:542–547, 2008.

\bibitem{MoralesEidingerBruce}
A.~Morales, D.~Eidinger, and A.W. Bruce.
\newblock {I}ntracavity {B}acillus {C}almette-{G}u\'{e}rin in the treatment of
  superficial bladder tumors.
\newblock {\em J. Urol}, 116:180--183, 1976.

\bibitem{bcg_good1}
H.~W. Herr, V.~P. Laudone, R.~A. Badalament, H.~F. Oettgen, P.~C. Sogani, B.~D.
  Freedman, M.~R. Melamed, and W.~F. Whitmore.
\newblock {B}acillus {C}almette-{G}u\'{e}rin therapy alters the progression of
  superficial bladder cancer.
\newblock {\em Journal of Clinical Oncology}, pages 1450--1455, 1988.

\bibitem{bcg_good3}
Redelman-Sidi G., Glickman M., and Bochner B.
\newblock The mechanism of action of bcg therapy for bladder cancer—a current
  perspective.
\newblock {\em Nature Reviews Urology}, 11:153--162, 2014.

\bibitem{bcg_good2}
Simon~M. P., O'Donnell~M. A., and Griffith~T. S.
\newblock Role of neutrophils in bcg immunotherapy for bladder cancer.
\newblock {\em Urologic Oncology: Seminars and Original Investigations}, pages
  341--345, 2008.

\bibitem{Guzev}
E.~Guzev, S.~Halachmi, and S.~Bunimovich-Mendrazitsky.
\newblock Additional extension of the mathematical model for bcg immunotherapy
  of bladder cancer and its validation by auxiliary tool.
\newblock {\em International Journal of Nonlinear Sciences and Numerical
  Simulation}, 2019.

\bibitem{CastiglionePiccoli}
F.~Castiglione and B.~Piccoli.
\newblock Cancer immunotherapy, mathematical modeling and optimal control.
\newblock {\em J. Theor. Biol.}, 247:723--732, 2007.

\bibitem{Byrne}
H.~M. Byrne.
\newblock Dissecting cancer through mathematics: From the cell to the animal
  model.
\newblock {\em Nature Reviews Cancer}, 10(3):221--230, 2010.

\bibitem{teddy_nano}
T.~Lazebnik, C.~Weitman, and G.~A. Kaminka.
\newblock Generic purpose pharmacokinetics-pharmacodynamics mathematical model
  for nanomedicine targeted drug delivery: Mouse model.
\newblock {\em bioRxiv}, 2022.

\bibitem{Kuznetsov}
V.~A. Kuznetsov, I.~A. Makalkin, M.~A. Taylor, and A.~S. Perelson.
\newblock Nonlinear dynamics of immunogenic tumours: Parameter estimation and
  global bifurcation analysis.
\newblock {\em Bull. Math. Biol.}, 56:295--321, 1994.

\bibitem{KimSteinberg}
J.~C. Kim and G.~D. Steinberg.
\newblock The limits of bacillus calmette–guérin for carcinoma in situ of
  the bladder.
\newblock {\em J. Urol.}, 165(3):745--756, 2001.

\bibitem{KirschnerPanetta}
D.~Kirschner and J.~C. Panetta.
\newblock Modeling immunotherapy of the tumor–immune interaction.
\newblock {\em J. Math. Biol.}, 37:235--252, 1998.

\bibitem{Panetta}
J.~C. Panetta.
\newblock A mathematical model of periodically pulsed chemotherapy: Tumor
  recurrence and metastasis in a competitive environment.
\newblock {\em Bull. Math. Biol.}, 58:425--447, 1996.

\bibitem{PillisRadunskaya}
L.~G. De~Pillis, A.~E. Radunskaya, and C.~L. Wiseman.
\newblock A validated mathematical model of cell-mediated immune response to
  tumor growth.
\newblock {\em Cancer Res.}, 65(17):7950--7958, 2005.

\bibitem{agent_spatial_location}
S.~Bunimovich-Mendrazitsky, V.~Pisarev, and E.~Kashdan.
\newblock Modeling and simulation of a low-grade urinary bladder carcinoma.
\newblock {\em Computers in Biology and Medicine}, 2014.

\bibitem{BunimovichGoltser}
S.~Bunimovich-Mendrazitsky and Y.~Goltser.
\newblock Use of quasi-normal form to examine stability of tumor-free
  equilibrium in a mathematical model of bcg treatment of bladder cancer.
\newblock {\em Math. Biosci. Eng.}, 8:529--547, 2011.

\bibitem{Nave}
O.~Nave, S.~Hareli, M.~Elbaz, I.~H. Iluz, and S.~Bunimovich-Mendrazitsky.
\newblock Bcg and il-2 model for bladder cancer treatment with fast and slow
  dynamics based on spvf method—stability analysis.
\newblock {\em Mathematical Biosciences and Engineering}, 16(5):5346--5379,
  2019.

\bibitem{BunimovichShochat}
S.~Bunimovich-Mendrazitsky, E.~Shochat, and L.~Stone.
\newblock Mathematical model of bcg immunotherapy in superficial bladder
  cancer.
\newblock {\em Bull. Math. Biol.}, 69(6):1847--1870, 2007.

\bibitem{math_good_1}
A.~Yaniv-Rosenfeld, E.~Savchenko, A.~Rosenfeld, and T.~Lazebnik.
\newblock Scheduling bcg and il-2 injections for bladder cancer immunotherapy
  treatment.
\newblock {\em Mathematics}, 11(5), 2023.

\bibitem{teddy_cells}
T.~Lazebnik.
\newblock Cell-level spatio-temporal model for a bacillus
  calmette–guérin-based immunotherapy treatment protocol of superficial
  bladder cancer.
\newblock {\em Cells}, 15(11):2372, 2022.

\bibitem{bcg_need_change_2}
E.~Ylösmäki, M.~Fusciello, B.~Martins, S.~Feola, F.~Hamdan, J.~Chiaro,
  L.~Ylosmaki, M.~J. Vaughan, T.~Viitala, P.~S. Kulkarni, and V.~Cerullo.
\newblock Novel personalized cancer vaccine platform based on bacillus
  calmette-guerin.
\newblock {\em Journal for immunotherapy of cancer}, 9(7):e002707, 2021.

\bibitem{teddy_extended}
T.~Lazebnik and S.~Bunimovich-Mendrazitsky.
\newblock Improved geometric configuration for the bladder cancer bcg-based
  immunotherapy treatment model.
\newblock {\em Bebis, G. and Gaasterland, T. and Kato, M. and Kohandel, M. and
  Wilkie, K. (eds) Mathematical and Computational Oncology, ISMCO}, 13060,
  2021.

\bibitem{bc_models_3}
C.~A. Rentsch, C.~Biot, J.~R. Gsponer, A.~Bachmann, M.~L. Albert, and
  R.~Breban.
\newblock Bcg-mediated bladder cancer immunotherapy: Identifying determinants
  of treatment response using a calibrated mathematical model.
\newblock {\em Plos One}, 8(2):1--6, 2013.

\bibitem{bc_models_2}
K.~E. Starkov and S.~Bunimovich-Mendrazitsky.
\newblock Dynamical properties and tumor clearance conditions for a
  nine-dimensional model of bladder cancer immunotherapy.
\newblock {\em American Institute of Mathematical Sciences}, 13(5):1059--1075,
  2016.

\bibitem{bc_ode_model_3}
Bunimovich-Mendrazitsky S., Halachmi S., and Kronik N.
\newblock Improving bacillus calmette guerin (bcg) immunotherapy for bladder
  cancer by adding interleukin-2 (il-2): a mathematical model.
\newblock {\em Mathematical Medicine and Biology}, pages 159--188, 2015.

\bibitem{bc_models_1}
D.~Song, T.~Powles, L.~Shi, L.~Zhang, M.~A. Ingersol, and Y-J. Lu.
\newblock Bladder cancer, a unique model to understand cancer immunity and
  develop immunotherapy approaches.
\newblock {\em The journal of Pathology}, 249(1):151--165, 2019.

\bibitem{pde_study_2}
S.~Eikenberry, C.~Thalhauser, and Y.~Kuang.
\newblock Tumor-immune interaction, surgical treatment, and cancer recurrence
  in a mathematical model of melanoma.
\newblock {\em Plos Computational Biology}, page e1000362, 2009.

\bibitem{newPaper}
T.~Lazebnik, S.~Bunimovich-Mendrazitsky, and N.~Haroni.
\newblock {PDE} based geometry model for {BCG} immunotherapy of bladder cancer.
\newblock {\em Biosystems}, 2021.

\bibitem{pde_study_1}
A.~Matzavinos, M.~A. Chaplain, and V.~A. Kuznetsov.
\newblock Mathematical modelling of the spatio-temporal response of cytotoxic
  t-lymphocytes to a solid tumour.
\newblock {\em Mathematical Medicine and Biology}, pages 1--34, 2004.

\bibitem{oldPaperOde}
L.~Shaikhet and S.~Bunimovich-Mendrazitsky.
\newblock Stability analysis of delayed immune response bcg infection in
  bladder cancer treatment model by stochastic perturbations.
\newblock {\em Computational and mathematical methods in medicine}, 2018.

\bibitem{bio_bg}
C.~Durek, S.~Brandau, A.~J. Ulmer, H-D. Flad, D.~Jocham, and A.~Bohle.
\newblock Bacillus-calmette-guerin (bcg) and 3d tumors: An in vitro model for
  the study of adhesion and invasion.
\newblock {\em Journal of Urology}, 162(2):600--605, 1999.

\bibitem{final_2_4}
T.~Lazebnik, Z.~Bahouth, S.~Bunimovich-Mendrazitsky, and S.~Halachmi.
\newblock Predicting acute kidney injury following open partial nephrectomy
  treatment using sat-pruned explainable machine learning model.
\newblock {\em BMC Medical Informatics and Decision Making}, 22:133, 2022.

\bibitem{final_2_3}
Y.~A. Veturi and et~al.
\newblock Syntheye: Investigating the impact of synthetic data on artificial
  intelligence-assisted gene diagnosis of inherited retinal disease.
\newblock {\em Ophthalmology Science}, 3(2):100258, 2023.

\bibitem{duration_1}
S.~Guallar-Garrido and Julian E.
\newblock Bacillus calmette-guerin (bcg) therapy for bladder cancer: An update.
\newblock {\em Immunotargets Ther.}, 13(9):1--11, 2020.

\bibitem{test_accuracy}
J.~Lee, K.~K. Won, C.~S. Hyun, H.~Jimi, and P.~S. Ho.
\newblock Systematic review and meta-analysis of studies evaluating diagnostic
  test accuracy: A practical review for clinical researchers-part ii.
  statistical methods of meta-analysis.
\newblock {\em kjr}, 16(6):1188--1196, 2015.

\bibitem{fsm}
V.~S. Alagar and K.~Periyasamy.
\newblock {\em Extended Finite State Machine}, pages 105--128.
\newblock Springer London, 2011.

\bibitem{k_fold}
R.~Kohavi.
\newblock A study of cross validation and bootstrap for accuracy estimation and
  model select.
\newblock In {\em International Joint Conference on Artificial Intelligence},
  1995.

\bibitem{liza_latest}
E.~Savchenko, A.~Rosenfeld, and S.~Bunimovich-Mendrazitsky.
\newblock Optimizing sms reminder campaigns for pre- and post-diagnosis cancer
  check-ups using socio-demographics: An in-silco investigation into bladder
  cancer.
\newblock {\em arXiv}, 2023.

\bibitem{gradient_descent_method}
Haskell~B Curry.
\newblock The method of steepest descent for non-linear minimization problems.
\newblock {\em Quarterly of Applied Mathematics}, 2(3):258--261, 1944.

\bibitem{numerical_scheme}
D.~W. Zingg.
\newblock Comparison of high-accuracy finite-difference methods for linear wave
  propagation.
\newblock {\em SIAM Journal on Scientific Computing}, 22(2):476--502, 2000.

\bibitem{gradient_descent}
S.~Ruder.
\newblock An overview of gradient descent optimization algorithms.
\newblock {\em arXiv}, 2016.

\bibitem{knn_bad_1}
D.~M. Hawkins.
\newblock The problem of overfitting.
\newblock {\em Journal of Chemical Information and Computer Sciences},
  44(1):1--12, 2004.

\bibitem{knn_bad_2}
R.~E. NcRoberts, E.~O. Tomppo, A.~O. Finley, and J.~Heikkinen.
\newblock Estimating areal means and variances of forest attributes using the
  k-nearest neighbors technique and satellite imagery.
\newblock {\em Remote Sensing of Environment}, 111(4):466--480, 2007.

\bibitem{tpot}
R.~S. Olson and J.~H. Moore.
\newblock Tpot: A tree-based pipeline optimization tool for automating machine
  learning.
\newblock In {\em Workshop on Automatic Machine Learning}, pages 66--74. PMLR,
  2016.

\bibitem{appendix}
R.~P. Agarwal and V.~Lakshmikantham.
\newblock Uniqueness and nonuniqueness criteria for ordinary differential
  equations.
\newblock {\em World Scientific}, 1993.

\bibitem{sveta_appendix}
S.~Bunimovich-Mendrazitsky, J.~C. {Gluckman}, and J.~Chaskalovic.
\newblock A mathematical model of combined bacillus calmette-guerin (bcg) and
  interleukin (il)-2 immunotherapy of superficial bladder cancer.
\newblock {\em Journal of Theoretical Biology}, 277(1):27--40, 2011.

\bibitem{final_appendix}
M.~Schatzman.
\newblock Numerical analysis: a mathematical introduction.
\newblock {\em Oxford Univ. Press.}, 2002.

\bibitem{stability}
P.~Parks.
\newblock A new proof of the routh-hurwitz stability criterion using the second
  method of liapunov.
\newblock {\em Mathematical Proceedings of the Cambridge Philosophical
  Society}, 58(4):694--702, 1962.

\bibitem{stability_2}
N.~Sternberg.
\newblock A hartman-grobman theorem for a class of retarded functional
  differential equations.
\newblock {\em Journal of Mathematical Analysis and Applications},
  176(1):156--165, 1993.

\bibitem{different_b_model}
E.~Guzev, S.~Halachmi, and S.~Bunimovich-Mendrazitsky.
\newblock Additional extension of the mathematical model for bcg immunotherapy
  of bladder cancer and its validation by auxiliary tool.
\newblock {\em International Journal of Nonlinear Sciences and Numerical
  Simulation}, 20(6):675--689, 2019.

\bibitem{volume_1}
M.~Lommatzschm, D.~Zingler, K.~Schuhbaeck, K.~Schloetcke, C.~Zingler,
  P.~Schuff-Werner, and J.~C. Virchow.
\newblock The impact of age, weight and gender on bdnf levels in human
  platelets and plasma.
\newblock {\em Neurobiology of Aging}, 26(1):115--123, 2005.

\bibitem{volume_2}
A.~M. Norris, E.~J. Laing, V.~E.~O. Valli, S.~J. Withrow, D.~W. Macy, G.~K.
  Ogilvie, J.~Tomlinson, D.~McCaw, G.~Pidgeon, and R.~M. Jacobs.
\newblock Canine bladder and urethral tumors: A retrospective study of 115
  cases (1980–1985).
\newblock {\em Journal of Veterinary Internal Medicine}, 6(3):145--153, 1992.

\bibitem{volume_3}
D.~W. Knapp, N.~W. Glickman, D.~B. DeNicola, P.~L. Bonney, T.~L. Lin, and L.~T.
  Glickman.
\newblock Naturally-occurring canine transitional cell carcinoma of the urinary
  bladder a relevant model of human invasive bladder cancer.
\newblock {\em Urologic Oncology: Seminars and Original Investigations},
  5(2):47--59, 2000.

\bibitem{cancer_cell_volume}
J.~Stella, L.~Bavaresco, E.~Braganhol, L.~Rockenbach, P.~F. Farias, M.~R. Wink,
  A.~A. Azambuja, C.~H. Barrios, F.~B. Morrone, and A.~M. {Oliveira
  Battastini}.
\newblock Differential ectonucleotidase expression in human bladder cancer cell
  lines.
\newblock {\em Urologic Oncology: Seminars and Original Investigations},
  28(3):260--267, 2010.

\bibitem{t_test}
D.~Kalpi{\'{c}}, N.~Hlupi{\'{c}}, and M.~Lovri{\'{c}}.
\newblock {\em Student's t-Tests}, pages 1559--1563.
\newblock 2011.

\bibitem{anova}
E.~R. Girden.
\newblock {\em ANOVA: Repeated measures}.
\newblock Number~84. Sage, 1992.

\bibitem{bc_summary_1}
R.~Nedeb and E.~M. Messing.
\newblock Gender, racial and age differences in bladder cancer incidence and
  mortality.
\newblock {\em Urologic Oncology: Seminars and Original Investigations},
  22(2):86--92, 2004.

\bibitem{bc_summary_2}
S.~Sasikumar, K.~A. M.~S. Wijayarathna, K. S. N.~andKarunaratne, U.~Gobi,
  A.~Pathmeswaran, and A.~M. Abeygunasekera1.
\newblock Pathological characteristics of primary bladder carcinoma treated at
  a tertiary care hospital and changing demographics of bladder cancer in sri
  lanka.
\newblock {\em Advances in Urology}, page 5751647, 2016.

\bibitem{bc_summary_3}
S.~K. Bhanvadia.
\newblock Bladder cancer survivorship.
\newblock {\em Current Urology Reports}, 19:111, 2018.

\bibitem{oldPaper}
T.~Lazebnik, S.~Yanetz, S.~Bunimovich-Mendrazitsky, and N.~Haroni.
\newblock Treatment of bladder cancer using bcg immunotherapy: Pde modeling.
\newblock {\em Partial Differential Equations}, 2020.

\bibitem{ariel_final}
A.~Rosenfeld and S.~Kraus.
\newblock {\em Predicting Human Decision-Making}.
\newblock 2018.

\end{thebibliography}
